Abstract:The study concerned the binding of sheep red blood cells by human peripheral blood lymphocytes. The results indicate that the phenomenon (rosette formation) is probably dependent on thymus‐derived lymphocytes (T lymphocytes) and not due to bone marrow lymphocytes (B lymphocytes). These data were obtained by a gradient centrifugation technique separating B lymphocytes from rosette‐forming cells, by direct study of B lymphocytes and rosette‐forming cells in the same preparations, and from the study of patients w… Show more
“…Furthermore, our data demonstrate that patients with low SIg do not contain appreciable amounts of TRFC. These data are similar to those obtained by others who studied TRFC in CLL patients with a high percentage of SIg' cells (7,8).…”
Section: Discussionsupporting
confidence: 81%
“…In the early studies only a relatively small population of peripheral blood lymphocytes formed rosettes (6,7,18,30); however, with some modifications in the technique, the studies of Jondal et al (8) as well as our own clearly indicate that the reaction between sheep erythrocytes and human lymphocytes is a quantitative marker for T cells and that in combination with markers for B cells such as SIg and CRL, all the lymphocytes in normal peripheral blood and thoracic duct can be accounted for.…”
Section: Discussionmentioning
confidence: 99%
“…In an effort to describe the B and T lymphocyte populations in humans, SIg and the complement receptor have been used to identify B cells and the recently described sheep E rosette-forming capacity used to identify T cells (6)(7)(8). Lymphocytes from normal individuals and individuals with CLL were studied.…”
Section: Discussionmentioning
confidence: 99%
“…In the mouse, T cells have the theta antigen and B cells do not. Human T cells can be identified by their lack of B cell markers and by their ability to form rosettes with sheep erythrocytes (6)(7)(8).…”
A B S T R A C T Human lymphocytes from normal peripheral blood, thymus, spleen, thoracic duct, and peripheral lymphocytes from patients with chronic lymphatic leukemia were studied for complement receptor sites (CRL), surface immunoglobulin (SIg), and for the ability to form rosettes with sheep erythrocytes (TRFC). The two B cell markers (CRL and SIg) were found to be in overlapping, but not totally identical populations, whereas cells that were able to form rosettes were found in a totally unrelated population of lymphocytes; TRFC is therefore probably a reliable marker for T cells. In peripheral blood 24% of lymphocytes had SIg, but only half of these were also CRL. Almost all of the non-SIg peripheral blood lymphocytes were TRFC. In the spleen and thoracic duct only a few lymphocytes were observed that had SIg and were not CRL. On the other hand, in two of three spleens studied 10-20% of cells were CRL that did not have SIg. In the thoracic duct all non-CRL, non-SIg cells were TRFC. In chronic lymphatic leukemia three findings were made: (a) The presence or absence of CRL was independent of the presence or absence of SIg so that in individuals whose cells were non-SIg, CRL were usually plentiful.
“…Furthermore, our data demonstrate that patients with low SIg do not contain appreciable amounts of TRFC. These data are similar to those obtained by others who studied TRFC in CLL patients with a high percentage of SIg' cells (7,8).…”
Section: Discussionsupporting
confidence: 81%
“…In the early studies only a relatively small population of peripheral blood lymphocytes formed rosettes (6,7,18,30); however, with some modifications in the technique, the studies of Jondal et al (8) as well as our own clearly indicate that the reaction between sheep erythrocytes and human lymphocytes is a quantitative marker for T cells and that in combination with markers for B cells such as SIg and CRL, all the lymphocytes in normal peripheral blood and thoracic duct can be accounted for.…”
Section: Discussionmentioning
confidence: 99%
“…In an effort to describe the B and T lymphocyte populations in humans, SIg and the complement receptor have been used to identify B cells and the recently described sheep E rosette-forming capacity used to identify T cells (6)(7)(8). Lymphocytes from normal individuals and individuals with CLL were studied.…”
Section: Discussionmentioning
confidence: 99%
“…In the mouse, T cells have the theta antigen and B cells do not. Human T cells can be identified by their lack of B cell markers and by their ability to form rosettes with sheep erythrocytes (6)(7)(8).…”
A B S T R A C T Human lymphocytes from normal peripheral blood, thymus, spleen, thoracic duct, and peripheral lymphocytes from patients with chronic lymphatic leukemia were studied for complement receptor sites (CRL), surface immunoglobulin (SIg), and for the ability to form rosettes with sheep erythrocytes (TRFC). The two B cell markers (CRL and SIg) were found to be in overlapping, but not totally identical populations, whereas cells that were able to form rosettes were found in a totally unrelated population of lymphocytes; TRFC is therefore probably a reliable marker for T cells. In peripheral blood 24% of lymphocytes had SIg, but only half of these were also CRL. Almost all of the non-SIg peripheral blood lymphocytes were TRFC. In the spleen and thoracic duct only a few lymphocytes were observed that had SIg and were not CRL. On the other hand, in two of three spleens studied 10-20% of cells were CRL that did not have SIg. In the thoracic duct all non-CRL, non-SIg cells were TRFC. In chronic lymphatic leukemia three findings were made: (a) The presence or absence of CRL was independent of the presence or absence of SIg so that in individuals whose cells were non-SIg, CRL were usually plentiful.
“…Spontaneous rosette formation between human T cells and erythrocytes from various species (Froland, 1972;Jondal et al, 1972;Amiot et al, 1984) has been a very useful phenomenon to identify, enumerate and separate human T lymphocytes. It has allowed significant progress in our knowledge of human T cell physiology, and has been used in therapy (Reisner et al, 1983).…”
These findings show that the E2 antigen, a cell surface molecule involved in T cell adhesion processes, is the product of the MIC2 gene, the only pseudoautosomal gene to be described in man.
Lymphocytes from eight patients with Hodgkin's disease were incubated with phytohemagglutinin (PHA) or pokeweed mitogen (PWM) over 7 days. Thymidine incorporation into DNA and ultrastructural features of transformed cells were studied. Response to these mitogens was either normal or diminished and/or delayed. In seven patients lymphocyte response to PHA was paralleled by a corresponding response to PWM. PHA‐transformed lymphocytes showed fine structural features similar to transformed normal cells. After PWM stimulation, blast cells and plasmacytoid cells in various stages of differentiation were observed. The number of transformed cells corresponded to the magnitude of thymidine incorporation and in cultures with normal PWM response, plasmacytoid cells occurred with almost normal frequency. If the specificity of the mitogens is as postulated, then patients with Hodgkin's disease do not have a selective loss of T lymphocytes. Furthermore, the findings suggest that in some patients there may be a functional impairment of both T and B lymphocytes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.